The Oncology Institute

TOI49

Penny Stock

$0.15arrow_drop_down1.29%-$0.00

Penny Stock

TOI49

$0.15

arrow_drop_down1.29%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.16
Prev. Close	$0.15
EPS	-0.77
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$11.63M
PE Ratio	-

	LOW	HIGH
Day Range	0.14	0.17
52 Week Range	0.12	2.65

Ratios

Revenue	-





EPS	-0.77

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About The Oncology Institute (TOI)

The Oncology Institute, Inc. (TOI) is a leading healthcare company in the field of oncology. With a strong history of providing top-quality care to cancer patients, TOI has made a name for itself as a trusted provider of innovative treatments and therapies. The company's stock price history reflects its success and growth over the years. Investors have seen steady increases in TOI's stock price, demonstrating the confidence and trust the market has in the company's future prospects. TOI's stock quote provides investors with real-time information on the current market value of the company's shares. This allows investors to make informed decisions based on the latest market trends and developments.

The Oncology Institute, Inc. is committed to transparency and regularly shares news updates with its shareholders and the general public. These news updates cover a range of topics, including new treatment options, research breakthroughs, and company initiatives. By staying up-to-date with TOI's stock news, investors can gain valuable insights into the company's progress and performance. TOI's stock analysis provides a comprehensive overview of the company's financial health and performance. This analysis takes into account various factors, including revenue growth, profitability, and market trends. Investors can use this analysis to assess the overall strength and stability of TOI as an investment opportunity.

Websitecall_made

Sector: Healthcare
Industry: Medical Care Facilities
CEO
Headquarters: Cerritos
Employees: 750
Exchange: NASDAQ

Keep an eye on The Oncology Institute

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is The Oncology Institute's (TOI) price per share?

The current price per share for The Oncology Institute (TOI) is $0.15. The stock has seen a price change of -$0 recently, indicating a -1.3% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for The Oncology Institute (TOI)?

For The Oncology Institute (TOI), the 52-week high is $2.66, which is 1.65K% from the current price. The 52-week low is $0.13, the current price is 20.63% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is The Oncology Institute (TOI) a growth stock?

The Oncology Institute (TOI) has shown an average price growth of -3.66% over the past three years. It has received a score of 5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying The Oncology Institute as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is The Oncology Institute (TOI) stock price performance year to date (YTD)?

As of the latest data, The Oncology Institute (TOI) has a year-to-date price change of -93.39%. Over the past month, the stock has experienced a price change of -53.66%. Over the last three months, the change has been -57.78%. Over the past six months, the figure is -71.05%.

help

Is The Oncology Institute (TOI) a profitable company?

The Oncology Institute (TOI) has a net income of -$83.07M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 18.37% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -16.6% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 28.42%, providing insight into the company's sales performance and growth. The gross profit is $59.57M. Operating income is noted at -$77.02M. Furthermore, the EBITDA is -$57.34M.

help

What is the market capitalization of The Oncology Institute (TOI)?

The Oncology Institute (TOI) has a market capitalization of $11.64M. The average daily trading volume is 0.16, indicating the stock's liquidity and investor engagement.